Neumora Therapeutics, Inc. (NMRA) stock
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.43−0.00 (-0.95%)
Close on Nov 13, 2026Market cap $80.59MP/E –Yield –
Neumora Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Neumora Therapeutics's price to book ratio was 1.8× on Nov 11, 2026, against 2.7× a year earlier. Over the last 2 years it ranged from 0.4× to 6.0×, with a median of 2.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | −0.3 |
| 2025 | Dec 31, 2025 | 2.2× | −0.9 |
| 2024 | Apr 30, 2024 | 3.1× | +2.0 |
| 2023 | Dec 29, 2023 | 1.1× | – |
See a number that looks wrong?